KBP-7018

N/A

Report date: 2022/01/05 15:24:33
NME

Base Information

Drug NameKBP-7018
Drug Alias NameKBP-7018
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cell growth factor receptor inhibitorsPlatelet-derived growth factor receptor inhibitorsTyrosine-protein kinase receptor RET inhibitors
TargetsPlatelet-derived growth factor receptor betaStem cell growth factor receptorTyrosine-protein kinase receptor RET
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Hengli Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Hengli Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A